The two will launch a joint pilot for R&D, production and marketing of cannabis- and mushroom-based nutritional supplements to be marketed in Israel and on the growing European market
The company is also planning to allocate Ambrosia-SupHerb 4.98% of its shares through a material private placement for approximately NIS 12 million, at a share price of NIS 5.26.
PR Newswire
TEL AVIV, Israel, Aug. 19, 2021